Q32 Bio Inc. (QTTB) Capital Expenditures (2017 - 2026)

Q32 Bio has reported Capital Expenditures for 10 years, with the latest figure at $233000.0 in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 30.9% year-over-year to $233000.0 in Q2 2026; TTM through Jun 2026 was $863000.0, a 12.66% increase from a year earlier, with the FY2025 full-year figure at $961000.0, up 12.27% from the prior year.
• Capital Expenditures was $233000.0 for Q2 2026 at Q32 Bio, up from $175000.0 in the prior quarter.
• The five-year high for Capital Expenditures was $3.9 million in Q4 2023, with the low at -$4000.0 in Q2 2024.
• Average Capital Expenditures over 5 years is $445166.7, with a median of $194500.0 recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures soared 43611.11% in 2023, then tumbled 105.19% in 2024.
• Over 5 years, Capital Expenditures stood at $9000.0 in 2022, then jumped by 43611.11% to $3.9 million in 2023, then tumbled by 93.54% to $254000.0 in 2024, then dropped by 16.93% to $211000.0 in 2025, then advanced by 10.43% to $233000.0 in 2026.
• The last three Capital Expenditures figures came in at $233000.0 (Q2 2026), $175000.0 (Q1 2026), and $211000.0 (Q4 2025), per Business Quant data.